HUMPHREY RACHEL

CIK 00015797815 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001579781

Recent Transactions

25 trades

Award
Pyxis Oncology, Inc.$PYXS
Stock Option (Right to Buy)
2026-03-24+45,867→ 45,867 total
Sale
Pyxis Oncology, Inc.$PYXS
Common Stock
2025-04-21$1.03/sh−13,896→ 81,309 total
Sale
Pyxis Oncology, Inc.$PYXS
Common Stock
2025-04-17$0.97/sh−200→ 95,205 total
Sale
Pyxis Oncology, Inc.$PYXS
Common Stock
2025-04-14$0.97/sh−1,400→ 95,405 total
Award
Pyxis Oncology, Inc.$PYXS
Stock Option (Right to Buy)
2025-03-31$0.98/sh+36,979→ 36,979 total
Award
Pyxis Oncology, Inc.$PYXS
Common Stock
2024-03-26+38,741→ 96,805 total
Award
Pyxis Oncology, Inc.$PYXS
Common Stock
2023-03-24+58,064→ 58,064 total
Award
Pyxis Oncology, Inc.$PYXS
Stock Option (Right to Buy)
2022-08-11+236,220→ 236,220 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2021-02-17+60,000→ 60,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-09-08+10,000→ 10,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2020-09-08+150,000→ 150,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (right to buy)
2019-01-25+90,000→ 90,000 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-03-02$6.61/sh+16,160→ 46,394 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-03-02$30.00/sh−16,160→ 30,234 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2018-03-02−16,160→ 222,980 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2018-02-28−23,840→ 239,140 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-02-28$30.00/sh−23,840→ 30,234 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-02-28$6.61/sh+23,840→ 54,074 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (right to buy)
2018-01-24+100,000→ 100,000 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2017-12-15$6.61/sh+15,117→ 30,234 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2017-12-15−15,117→ 262,980 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (right to buy)
2017-01-25+120,000→ 120,000 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2016-12-28−15,117→ 278,097 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2016-12-28$6.61/sh+15,117→ 15,117 total
Award
CytomX Therapeutics, Inc.$CTMX
Employee Stock Option (right to buy)
2016-01-21+65,000→ 65,000 total

Companies

Recent Filings

Address

C/O PYXIS ONCOLOGY, INC. 321 HARRISON AVENUE, 11TH FL. SUITE 1

BOSTON, MA, 02118

View on SEC.gov